Showing results (61-70 of 292) with videos related to
Sort By:
Pageof 30
American Heart Journal|December 1, 1996
Recombinant growth hormone: a new cardiovascular drug therapyM Gomberg-Maitland, W H FrishmanThe American Journal of Cardiology|November 6, 1990
Reduction of mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockadeW H Frishman, E J LazarAmerican Heart Journal|March 7, 1998
Thyroid hormone and cardiovascular diseaseM Gomberg-Maitland, W H FrishmanJournal of Cardiovascular Pharmacology|January 1, 1988
Calcium channel blockers in patients with both hypertension and angina pectorisW H Frishman, E J LazarHeart Disease (Hagerstown, Md.)|April 27, 2002
Systemic inflammation as a cardiovascular disease risk factor and as a potential target for drug therapyR C Kaplan, W H FrishmanCardiology Clinics|November 1, 1987
The pathophysiology and management of primary pulmonary hypertensionS A Fein, W H FrishmanJournal of Clinical Pharmacology|March 20, 1998
Matrix metalloproteinases and coronary artery disease: a novel therapeutic targetD C Celentano, W H FrishmanJournal of Clinical Pharmacology|May 23, 1998
Fenoldopam: a new dopamine agonist for the treatment of hypertensive urgencies and emergenciesJ B Post, W H FrishmanHeart Disease (Hagerstown, Md.)|December 1, 2001
Adrenomedullin: a vasoactive and natriuretic peptide with therapeutic potentialJ J Lah, W H FrishmanHeart Disease (Hagerstown, Md.)|April 27, 2002
The role of tumor necrosis factor in cardiac diseaseA S Retter, W H FrishmanPageof 30